964 related articles for article (PubMed ID: 12375320)
1. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
Bhat NM; Lee LM; van Vollenhoven RF; Teng NN; Bieber MM
J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320
[TBL] [Abstract][Full Text] [Related]
2. VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics.
van Vollenhoven RF; Bieber MM; Powell MJ; Gupta PK; Bhat NM; Richards KL; Albano SA; Teng NN
J Rheumatol; 1999 Aug; 26(8):1727-33. PubMed ID: 10451069
[TBL] [Abstract][Full Text] [Related]
3. Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus.
Stevenson FK; Longhurst C; Chapman CJ; Ehrenstein M; Spellerberg MB; Hamblin TJ; Ravirajan CT; Latchman D; Isenberg D
J Autoimmun; 1993 Dec; 6(6):809-25. PubMed ID: 8155258
[TBL] [Abstract][Full Text] [Related]
4. Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus.
Yoshio T; Masuyama J; Ikeda M; Tamai K; Hachiya T; Emori T; Mimori A; Takeda A; Minota S; Kano S
J Rheumatol; 1995 Sep; 22(9):1681-7. PubMed ID: 8523345
[TBL] [Abstract][Full Text] [Related]
5. IgG Subclasses and Isotypes of VH4-34 Encoded Antibodies.
Bhat NM; Kshirsagar MA; Bieber MM; Teng NN
Immunol Invest; 2015; 44(4):400-10. PubMed ID: 25942350
[TBL] [Abstract][Full Text] [Related]
6. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
7. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
Guo H; Leung JC; Chan LY; Chan TM; Lai KN
Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
[TBL] [Abstract][Full Text] [Related]
8. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
Cambridge G; Isenberg DA; Edwards JC; Leandro MJ; Migone TS; Teodorescu M; Stohl W
Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
[TBL] [Abstract][Full Text] [Related]
9. Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus.
Molina JF; Gutierrez-Ureña S; Molina J; Uribe O; Richards S; De Ceulaer C; Garcia C; Wilson WA; Gharavi AE; Espinoza LR
J Rheumatol; 1997 Feb; 24(2):291-6. PubMed ID: 9034985
[TBL] [Abstract][Full Text] [Related]
10. Individual variation in the isotype profile of anti-histone autoantibodies in systemic lupus erythematosus.
Fellows G; Gittoes N; Scott DG; Coppock JS; Wainwright A; Goodall M; Turner BM
Clin Exp Immunol; 1988 Jun; 72(3):440-5. PubMed ID: 3262462
[TBL] [Abstract][Full Text] [Related]
11. VH4.21-encoded natural autoantibodies with anti-i specificity mirror those associated with cold hemagglutinin disease.
Schutte ME; van Es JH; Silberstein LE; Logtenberg T
J Immunol; 1993 Dec; 151(11):6569-76. PubMed ID: 7504024
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of a germ line-encoded idiotypic marker of pathogenic human lupus autoantibodies.
Young F; Tucker L; Rubinstein D; Guillaume T; André-Schwartz J; Barrett KJ; Schwartz RS; Logtenberg T
J Immunol; 1990 Oct; 145(8):2545-53. PubMed ID: 2120334
[TBL] [Abstract][Full Text] [Related]
14. Antibody clustering helps refine lupus prognosis.
Kessel A; Rosner I; Halasz K; Grushko G; Shoenfeld Y; Paran D; Toubi E
Semin Arthritis Rheum; 2009 Aug; 39(1):66-70. PubMed ID: 18538829
[TBL] [Abstract][Full Text] [Related]
15. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
16. Anticardiolipin antibodies and disease activity in systemic lupus erythematosus.
Santiago MB; Viana V; Bueno C; Yoshinari N; de Oliveira RM; Cossermelli W
Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(4):167-70. PubMed ID: 2135827
[TBL] [Abstract][Full Text] [Related]
17. [Anticardiolipin antibodies in cutaneous lupus erythematosus. Incidence and importance as a marker of vascular symptoms].
Tebbe B; Orfanos CE
Hautarzt; 1992 Mar; 43(3):130-3. PubMed ID: 1577600
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to histones of the IgG and IgM class in systemic lupus erythematosus.
Krippner H; Springer B; Merle S; Pirlet K
Clin Exp Immunol; 1984 Oct; 58(1):49-56. PubMed ID: 6332696
[TBL] [Abstract][Full Text] [Related]
19. A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythematosus.
Yoshio T; Masuyama JI; Minota S; Kaneko N; Iwamoto M; Okazaki H; Mimori A; Takeda A; Kano S
J Rheumatol; 1998 Apr; 25(4):681-8. PubMed ID: 9558169
[TBL] [Abstract][Full Text] [Related]
20. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
Williams RC; Malone CC; Meyers C; Decker P; Muller S
J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]